Skip to content

HEMAGEN DIAGNOSTICS INC

company.status.inactive

CIK 892822fmd_0CGWJXZQV23Q9X1D3TM3D083EPManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Oct 01, 2009 to Sep 30, 2012, 10 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012
Total revenues554
Cost of revenue332
Gross profit222
Research and development000
Selling, general and administrative222
Total operating expenses222
Operating income0(0)(0)
Interest expense(0)00
Other non-operating income (expense)–(0)(0)
Income before taxes(0)(1)(1)
Income tax expense(0)(0)–
Net income from continuing operations0(1)–
Net income(0)(1)(1)